{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:05:03Z","timestamp":1791173103462,"version":"4.1.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What are the outcomes of pregnancies exposed to hydroxychloroquine (HCQ) in women with a history of recurrent pregnancy loss (RPL), and what factors predict the course of these pregnancies beyond the first trimester?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>In our cohort of pregnancies in women with a history of RPL exposed to HCQ early in pregnancy, we found that the only factor determining the success of these pregnancies was the number of previous miscarriages.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Dysregulation of the maternal immune system plays a role in RPL. HCQ, with its dual immunomodulating and vascular protective effects, is a potential treatment for unexplained RPL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>The FALCO (Facteurs de r\u00e9cidive pr\u00e9coce des fausses couches) registry is an ongoing French multicenter infertility registry established in 2017 that includes women (aged from 18 to 49\u2009years) with a history of spontaneous RPL (at least three early miscarriages (\u226412\u2009weeks of gestation (WG)) recruited from several university hospitals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Spontaneous pregnancies enrolled in the FALCO registry with an exposure to HCQ (before conception or at the start of pregnancy) were included. Pregnancies concomitantly exposed to tumor necrosis factor inhibitors, interleukin-1 and -2 inhibitors, intravenous immunoglobulin, and\/or intravenous intralipid infusion, were excluded. Concomitant treatment with low-dose aspirin (LDA), low-molecular weight heparin (LMWH), progesterone, and\/or prednisone was allowed. All patients underwent the recommended evaluations for investigating RPL. Those who became pregnant received obstetric care in accordance with French recommendations and were followed prospectively. The main endpoint was the occurrence of a pregnancy continuing beyond 12 WG, and the secondary endpoint was the occurrence of a live birth.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>One hundred pregnancies with HCQ exposure in 74 women were assessed. The mean age of the women was 34.2\u2009years, and the median number of previous miscarriages was 5. Concomitant exposure was reported in 78 (78%) pregnancies for prednisone, 56 (56%) pregnancies for LDA, and 41 (41%) pregnancies for LMWH. Sixty-two (62%) pregnancies ended within 12 WG, the other 38 (38%) continuing beyond 12 WG. The risk of experiencing an additional early spontaneous miscarriage increased with the number of previous miscarriages, but not with age. The distributions of anomalies identified in RPL investigations and of exposure to other drugs were similar between pregnancies lasting \u226412 WG and those continuing beyond 12WG. The incidence of pregnancies progressing beyond 12 WG was not higher among pregnancies with at least one positive autoantibody (Ab) (i.e. antinuclear Ab titer \u22651:160, \u22651 positive conventional and\/or non-conventional antiphospholipid Ab, and\/or positive results for \u22651 antithyroid Ab) without diminished ovarian reserve (18\/51, 35.3%) than among those without such autoantibody (18\/45, 40.0%) (P\u2009=\u20090.63). Multivariate analysis showed that having \u22644 prior miscarriages was the only factor significantly predictive for achieving a pregnancy &amp;gt; 12 WG, after adjustment for age and duration of HCQ use prior to conception (adjusted odds ratio (OR)\u2009=\u20093.13 [1.31\u20137.83], P\u2009=\u20090.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>Our study has limitations, including the absence of a control group, incomplete data for the diagnostic procedure for RPL in some patients, and the unavailability of results from endometrial biopsies, as well as information about paternal age and behavioral factors. Consequently, not all potential confounding factors could be considered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Exposure to HCQ in early pregnancy for women with a history of RPL does not seem to prevent further miscarriages, suggesting limited impact on mechanisms related to the maternal immune system.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>The research received no specific funding, and the authors declare no competing interests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>clinicaltrial.gov NCT05557201.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deae146","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T01:12:06Z","timestamp":1719623526000},"page":"1934-1941","source":"Crossref","is-referenced-by-count":19,"title":["Hydroxychloroquine in recurrent pregnancy loss: data from a French prospective multicenter registry"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-8764","authenticated-orcid":false,"given":"Amandine","family":"Dernoncourt","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Interne et RECIF, Centre Hospitalo-Universitaire Amiens-Picardie , Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaies","family":"Hedhli","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019H\u00e9matologie, Centre de Biologie Humaine, Centre Hospitalo-Universitaire Amiens-Picardie , Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Abisror","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Inflammation-Immunopathology-Biotherapy Department (DMU I3), H\u00f4pital Saint Antoine, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryam","family":"Cheloufi","sequence":"additional","affiliation":[{"name":"Service de Gyn\u00e9cologie Obst\u00e9trique, H\u00f4pital Armand-Trousseau, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cohen","sequence":"additional","affiliation":[{"name":"Service d\u2019Obst\u00e9trique et de Fertilit\u00e9, Clinique Saint Th\u00e9r\u00e8se , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Kolanska","sequence":"additional","affiliation":[{"name":"Service de Gyn\u00e9cologie Obst\u00e9trique et M\u00e9decine de la Reproduction, Centre de Fertilit\u00e9 Tenon, H\u00f4pital Tenon, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"McAvoy","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Inflammation-Immunopathology-Biotherapy Department (DMU I3), H\u00f4pital Saint Antoine, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Selleret","sequence":"additional","affiliation":[{"name":"Service de Gyn\u00e9cologie Obst\u00e9trique et M\u00e9decine de la Reproduction, Centre de Fertilit\u00e9 Tenon, H\u00f4pital Tenon, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ballot","sequence":"additional","affiliation":[{"name":"Service d\u2019Immunologie, H\u00f4pital Saint Antoine, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Mathieu d\u2019Argent","sequence":"additional","affiliation":[{"name":"Service de Gyn\u00e9cologie Obst\u00e9trique et M\u00e9decine de la Reproduction, Centre de Fertilit\u00e9 Tenon, H\u00f4pital Tenon, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6525-4154","authenticated-orcid":false,"given":"Nathalie","family":"Chabbert Buffet","sequence":"additional","affiliation":[{"name":"Service de Gyn\u00e9cologie Obst\u00e9trique et M\u00e9decine de la Reproduction, Centre de Fertilit\u00e9 Tenon, H\u00f4pital Tenon, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Inflammation-Immunopathology-Biotherapy Department (DMU I3), H\u00f4pital Saint Antoine, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Kayem","sequence":"additional","affiliation":[{"name":"Service de Gyn\u00e9cologie Obst\u00e9trique, H\u00f4pital Armand-Trousseau, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2849-3049","authenticated-orcid":false,"given":"Ars\u00e8ne","family":"Mekinian","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Inflammation-Immunopathology-Biotherapy Department (DMU I3), H\u00f4pital Saint Antoine, Sorbonne Universit\u00e9 AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"2024090414361940600_deae146-B1","doi-asserted-by":"crossref","first-page":"e001340","DOI":"10.1136\/rmdopen-2020-001340","article-title":"Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study","volume":"6","author":"Abisror","year":"2020","journal-title":"RMD Open"},{"key":"2024090414361940600_deae146-B2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2024090414361940600_deae146-B3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0049124104268644","article-title":"Multimodel inference: understanding AIC and BIC in model selection","volume":"33","author":"Burnham","year":"2004","journal-title":"Sociol Methods Res"},{"key":"2024090414361940600_deae146-B4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0015-0282(00)01801-X","article-title":"Karyotype of the abortus in recurrent miscarriage","volume":"75","author":"Carp","year":"2001","journal-title":"Fertil Steril"},{"key":"2024090414361940600_deae146-B5","doi-asserted-by":"crossref","first-page":"103986","DOI":"10.1016\/j.jri.2023.103986","article-title":"The use of immunotherapies for recurrent miscarriage: an overview of systematic reviews and meta-analysis","volume":"158","author":"Cavalcante","year":"2023","journal-title":"J Reprod Immunol"},{"key":"2024090414361940600_deae146-B6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.molmed.2023.05.009","article-title":"Immunobiology of pregnancy: from basic science to translational medicine","volume":"29","author":"Colamatteo","year":"2023","journal-title":"Trends Mol Med"},{"key":"2024090414361940600_deae146-B7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bcp.14131","article-title":"Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage","volume":"86","author":"de Moreuil","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"2024090414361940600_deae146-B8","doi-asserted-by":"crossref","first-page":"1759720X211073001","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2024090414361940600_deae146-B9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","article-title":"Recurrent pregnancy loss","volume":"6","author":"Dimitriadis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2024090414361940600_deae146-B10","doi-asserted-by":"crossref","first-page":"hoad002","DOI":"10.1093\/hropen\/hoad002","article-title":"ESHRE guideline: recurrent pregnancy loss: an update in 2022","volume":"2023","author":"ESHRE Guideline Group on RPL","year":"2023","journal-title":"Hum Reprod Open"},{"key":"2024090414361940600_deae146-B11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.fertnstert.2013.11.004","article-title":"The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening","volume":"101","author":"Franasiak","year":"2014","journal-title":"Fertil Steril"},{"key":"2024090414361940600_deae146-B12","doi-asserted-by":"crossref","first-page":"849692","DOI":"10.3389\/fphar.2022.849692","article-title":"Treatment of refractory\/high-risk pregnancies with antiphospholipid syndrome: a systematic review of the literature","volume":"13","author":"Hoxha","year":"2022","journal-title":"Front Pharmacol"},{"key":"2024090414361940600_deae146-B13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.fertnstert.2020.10.051","article-title":"Diminished ovarian reserve is associated with reduced euploid rates via preimplantation genetic testing for aneuploidy independently from age: evidence for concomitant reduction in oocyte quality with quantity","volume":"115","author":"Jaswa","year":"2021","journal-title":"Fertil Steril"},{"key":"2024090414361940600_deae146-B14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2020.12.005","article-title":"Role of the sperm, oocyte, and embryo in recurrent pregnancy loss","volume":"115","author":"Klimczak","year":"2021","journal-title":"Fertil Steril"},{"key":"2024090414361940600_deae146-B15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10815-022-02414-2","article-title":"Recurrent pregnancy loss: fewer chromosomal abnormalities in products of conception? A meta-analysis","volume":"39","author":"Lei","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2024090414361940600_deae146-B16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/AOG.0b013e31823c0413","article-title":"Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success?","volume":"119","author":"Lund","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2024090414361940600_deae146-B17","doi-asserted-by":"crossref","first-page":"l869","DOI":"10.1136\/bmj.l869","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study","volume":"364","author":"Magnus","year":"2019","journal-title":"BMJ"},{"key":"2024090414361940600_deae146-B18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aji.12493","article-title":"Unexplained recurrent miscarriage and recurrent implantation failure: is there a place for immunomodulation?","volume":"76","author":"Mekinian","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"2024090414361940600_deae146-B19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2024090414361940600_deae146-B20","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1080\/01443615.2022.2141615","article-title":"The effect of hydroxychloroquine on pregnancy outcomes in patients with unexplained recurrent pregnancy loss: a placebo-controlled study \u201cpilot study\u201d","volume":"42","author":"Moini","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"2024090414361940600_deae146-B21","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/art.10307","article-title":"Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis","volume":"46","author":"Munster","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2024090414361940600_deae146-B22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","article-title":"A caution regarding rules of thumb for variance inflation factors","volume":"41","author":"O\u2019Brien","year":"2007","journal-title":"Qual Quant"},{"key":"2024090414361940600_deae146-B23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0015-0282(99)00495-1","article-title":"Embryonic karyotype of abortuses in relation to the number of previous miscarriages","volume":"73","author":"Ogasawara","year":"2000","journal-title":"Fertil Steril"},{"key":"2024090414361940600_deae146-B24","doi-asserted-by":"crossref","first-page":"e025649","DOI":"10.1136\/bmjopen-2018-025649","article-title":"Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study","volume":"9","author":"Pasquier","year":"2019","journal-title":"BMJ Open"},{"key":"2024090414361940600_deae146-B25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.fertnstert.2020.12.010","article-title":"Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis","volume":"115","author":"Pirtea","year":"2021","journal-title":"Fertil Steril"},{"key":"2024090414361940600_deae146-B26","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"2024090414361940600_deae146-B27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2024090414361940600_deae146-B28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the Lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"2024090414361940600_deae146-B29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1186\/s13063-020-04716-1","article-title":"A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial","volume":"21","author":"Yang","year":"2020","journal-title":"Trials"},{"key":"2024090414361940600_deae146-B30","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2020.10.031","article-title":"Successful implantation is associated with a transient increase in serum pro-inflammatory cytokine profile followed by a switch to anti-inflammatory cytokine profile prior to confirmation of pregnancy","volume":"115","author":"Zhao","year":"2021","journal-title":"Fertil Steril"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/9\/1934\/59018324\/deae146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/9\/1934\/59018324\/deae146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:34:14Z","timestamp":1725525254000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/39\/9\/1934\/7701426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,6,28]]},"published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deae146","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,6,28]]}}}